Denis Chem Lab Ltd.
Snapshot View

81.90 -0.60 ▼-0.7%

03 October 2022, 12:36:00 PM
Volume: 2,340

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.denischemlab.com
Market Cap 114.14 Cr.
Enterprise Value(EV) 108.48 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 4.90 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 16.80 Trailing Twelve Months Ending 2022-06
Industry PE 31.52 Trailing Twelve Months Ending 2022-06
Book Value / Share 49.43 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.66 Calculated using Price: 82.25
Dividend Yield 1.82 Period Ending 2022-03
No. of Shares Subscribed 1.39 Cr. 13,876,668 Shares
FaceValue 10
Company Profile
The company is engaged in the business of manufacturing of Pharmaceuticals Transfusion Solution in Bottles. It offers wide range of sterile intravenous injectables for human and veterinary consumption. The company's product offerings comprise of various products sold across several states in India. It also exports sterile intravenous medicines to countries like Sri Lanka, Nepal, Combodia, Vietnam, Somalia, Ivory Cost etc. In addition to manufacturing its own products which it sells under its own brands, it does manufacture products on contract basis for third parties including certain multinational pharmaceutical companies who market such products under their own brands.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.73%
1 Week
-0.97%
1 Month
+1.11%
3 Month
+48.37%
6 Month
+10.68%
1 Year
+24.47%
2 Year
+105.52%
5 Year
-20.72%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 14.13 0.62 -30.41 5.86 5.37 11.94 7.29 3.76 9.79
Return on Capital Employed (%) 15.80 10.93 5.30 12.19 9.37 11.90 11.34 6.50 13.79
Return on Assets (%) 2.87 0.12 -5.36 1.38 2.20 6.15 4.15 2.39 6.64

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 8 9 17 16 30 50 56 59 62 66
Non Curr. Liab. 5 18 25 22 20 11 6 4 6 5
Curr. Liab. 21 25 39 46 44 40 43 34 25 25
Minority Int.
Equity & Liab. 35 52 81 85 94 101 106 97 92 96
Non Curr. Assets 11 19 44 51 46 48 51 47 44 43
Curr. Assets 24 33 37 34 48 53 54 50 49 53
Misc. Exp. not W/O
Total Assets 35 52 81 85 94 101 106 97 92 96

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 67 77 100 113 107 124 136 109 137 143
Other Income 0 0 0 1 1 2 0 0 1 1
Total Income 68 77 100 114 108 126 136 110 138 144
Total Expenditure -61 -68 -91 -99 -95 -110 -121 -99 -122 -128
PBIDT 6 10 9 15 13 16 15 11 15 16
Interest -3 -5 -7 -6 -5 -3 -3 -2 -1 -1
Depreciation -1 -4 -6 -7 -6 -6 -7 -6 -6 -6
Taxation -1 0 -1 -1 0 0 -2 -1 -3 -3
Exceptional Items
PAT 1 0 -4 1 2 6 4 2 6 7
Adjusted EPS 4 0 -5 1 2 5 3 2 5 5

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1 -2 14 21 7 11 8 13 8 17
Cash Fr. Inv. -1 -9 -28 -13 -1 -16 -2 -2 -1 -10
Cash Fr. Finan. 4 12 13 -7 0 1 -5 -14 -6 -7
Net Change 1 0 -1 1 5 -4 1 -3 1 0
Cash & Cash Eqvt 2 3 2 3 6 2 3 0 2 1

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 38.98 38.98 38.98 38.98 38.98 38.98 38.98 38.98 38.98
Public 61.02 61.02 61.02 61.02 61.02 61.02 61.02 61.02 61.02
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 28 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Declaration of Results of Resolutions passed at the 41St Annual General Meeting held through VC/OAVM and Submission of Scrutineers Report thereon.
Wed, 28 Sep 2022
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
This is to inform you that the Members in their 41stAnnual General Meeting held on Wednesday the 28th September 2022 have appointed M/s Shah & Shah Associates Chartered Accountants (Firm Registration No.113742W) Ahmedabad as Statutory Auditors of the Company for a period of 5 years from the conclusion of 41st Annual General Meeting till the Conclusion of the 46th Annual General Meeting to be held in the year 2027.
Wed, 28 Sep 2022
Announcement Under Regulation 30 (LODR) - Proceedings Of 41ST Annual General Meeting Held Through VC/OAVM
We are enclosing herewith copy of the Minutes of the 41ST Annual General Meeting of the Company held on 28th September 2022 through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM) for your records.

Technical Scans View Details >>

Fri, 30 Sep 2022
High Delivery Percentage High Delivery Percentage
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
High Increase 2 Years High Increase 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 227,696.89 962.55 +1.5%
Divi's Laboratories Ltd. 97,811.90 3,791.95 +2.3%
Cipla Ltd. 89,996.82 1,144.45 +2.6%
Dr. Reddy's Laboratories Ltd. 72,145.56 4,405.50 +1.6%
Apollo Hospitals Enterprise Ltd. 62,833.90 4,447.90 +1.5%
Torrent Pharmaceuticals Ltd. 52,506.43 1,588.70 +1.8%
Abbott India Ltd. 40,438.70 18,882.25 -1.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.54 962.55 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,791.95 +2.3%
Cipla Ltd. Consolidated 2022-06 36.17 1,144.45 +2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.12 4,405.50 +1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.12 4,447.90 +1.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.55 1,588.70 +1.8%
Abbott India Ltd. Standalone 2022-06 50.01 18,882.25 -1.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.54 962.55 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,791.95 +2.3%
Cipla Ltd. Consolidated 2022-06 4.19 1,144.45 +2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.56 4,405.50 +1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.57 4,447.90 +1.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.21 1,588.70 +1.8%
Abbott India Ltd. Standalone 2022-06 13.56 18,882.25 -1.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 962.55 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,791.95 +2.3%
Cipla Ltd. Consolidated 2022-03 0.04 1,144.45 +2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,405.50 +1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,447.90 +1.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,588.70 +1.8%
Abbott India Ltd. Standalone 2022-03 0.00 18,882.25 -1.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 962.55 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,791.95 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,144.45 +2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,405.50 +1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,447.90 +1.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,588.70 +1.8%
Abbott India Ltd. Standalone 2022-03 29.95 18,882.25 -1.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 962.55 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,791.95 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,144.45 +2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,405.50 +1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,447.90 +1.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,588.70 +1.8%
Abbott India Ltd. Standalone 2022-03 29.95 18,882.25 -1.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 962.55 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,791.95 +2.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,144.45 +2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,405.50 +1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,447.90 +1.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,588.70 +1.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 18,882.25 -1.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 962.55 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,791.95 +2.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,144.45 +2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,405.50 +1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,447.90 +1.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,588.70 +1.8%
Abbott India Ltd. Standalone 2022-03 798.70 18,882.25 -1.3%

FAQ's On Denis Chem Lab Ltd.

What is Denis Chem Lab share price?

Can I buy Denis Chem Lab shares now?

What is the Dividend Yield of Denis Chem Lab?

What is the Market Cap of Denis Chem Lab?

What are the key metrics to analyse Denis Chem Lab?

What is the 52 Week High and Low of Denis Chem Lab?

What is the trend of Denis Chem Lab share price?